You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海王生物(000078.SZ):2020年度由盈轉虧 預虧2.7億元–3.8億元
格隆匯 01-29 22:03

格隆匯 1 月 29日丨海王生物(000078.SZ)披露2020年年度業績預吿,預計2020年年度歸屬於上市公司股東的淨虧損2.7億元–3.8億元,上年同期盈利2.41億元;扣除非經常性損益後的淨虧損3.4億元–4.5億元,上年同期盈利5210.50萬元。業績變動主要原因如下:

1、受新冠肺炎疫情影響,公立醫療機構控制除發熱門診外的接診病人,尤其是公司重要子公司湖北海王醫藥集團有限公司及其下屬公司所在區域的公立醫療機構,除疫情相關物資和藥品外的其他藥品和器械耗材採購量大幅下降,導致公司營業收入和毛利率下滑。

2、計提商譽減值準備。受新冠肺炎疫情影響,公司下屬子公司營業收入和毛利率下滑,導致部分下屬子公司業績同比下降幅度較大。公司根據《會計監管風險提示第8號—商譽減值》及《企業會計準則第8號—資產減值》的相關要求,對前期收購子公司形成的商譽進行了初步減值測試,預計本期計提的商譽減值額為5.1億元-5.8億元(實際計提金額需依據評估機構出具的商譽減值測試評估報吿確定),導致公司本報吿期業績大幅下降。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account